All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
| WVE / Wave Life Sciences Ltd.
|
|
|
|
|
|
|
|
| DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| MRUS / Merus N.V.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| VTAE / Vitae Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
| US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| RGLS / Regulus Therapeutics Inc.
|
|
|
|
|
|
|
|
| NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
| SIOX / Sio Gene Therapies Inc.
|
|
|
|
|
|
|
|
| ZYNE / Zynerba Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| DMTX / Dimension Therapeutics, Inc.
|
|
|
|
|
|
|
|
| PATI / Patriot Transportation Holding, Inc.
|
|
|
|
|
|
|
|
| AVXS / AveXis, Inc.
|
|
|
|
|
|
|
|
| ACOR / Acorda Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AGRX / Agile Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARCT / Arcturus Therapeutics Holdings Inc.
|
|
|
|
|
|
|
|
| EIGR / Eiger BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TENX / Tenax Therapeutics, Inc.
|
|
|
|
|
|
|
|
| 0HBB / Aimmune Therapeutics Inc
|
|
|
|
|
|
|
|
| ABIO / ARCA biopharma, Inc.
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| ARMP / Armata Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc
|
|
|
|
|
|
|
|
| ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
| BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AGLE / Aeglea BioTherapeutics Inc
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| AGTC / Applied Genetic Technologies Corp
|
|
|
|
|
|
|
|
| DSCI / Derma Sciences, Inc.
|
|
|
|
|
|
|
|
| NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CDTX / Cidara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SGMO / Sangamo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ARDX / Ardelyx, Inc.
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S
|
|
|
|
|
|
|
|
| TARA / Protara Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
